Literature DB >> 21182929

Brain homeostasis is maintained by "danger" signals stimulating a supportive immune response within the brain's borders.

Noga Ron-Harel1, Michal Cardon, Michal Schwartz.   

Abstract

An organism's behavior is determined by the way it senses and perceives the surrounding environment, and by its responses to these stimuli. The major factors known to affect the behavioral response to an event are genetic background, environmental factors, and past experiences, and their imprinting on the relevant brain circuits. Recently, circulating immune cells were introduced as novel players into this system. It was proposed that the brain and circulating immune cells engage in a continuous dialogue that takes place within the brain's territory, though outside the parenchyma (occurring within the brain's borders - the choroid plexi, the brain meninges and the cerebrospinal fluid (CSF)). The cytokines secreted by activated leukocytes residing at the borders were shown to affect neurotrophic factors production within the parenchyma. Here, we suggest that such a dialogue is stimulated at the brain's borders, upon need, by a "danger" signal that originates in the parenchyma in response to any destabilizing event, and discuss the potential role of reactive oxygen species (ROS) in transmitting this signal. Accordingly, a failure to restore balance is likely to lead to aberrant responses to subsequent events. This view thus supports the contention that circulating immune cells are required to maintain the brain's balanced activity and suggests a novel mechanism whereby the surveying immune cells are sensing the brain's status and needs.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21182929     DOI: 10.1016/j.bbi.2010.12.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  15 in total

Review 1.  Cross-talk between neural stem cells and immune cells: the key to better brain repair?

Authors:  Zaal Kokaia; Gianvito Martino; Michal Schwartz; Olle Lindvall
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

2.  Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand.

Authors:  Merav Cohen; Hila Ben-Yehuda; Ziv Porat; Catarina Raposo; Siamon Gordon; Michal Schwartz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

Review 3.  Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics.

Authors:  Harris Eyre; Bernhard T Baune
Journal:  J Neural Transm (Vienna)       Date:  2012-06-01       Impact factor: 3.575

Review 4.  How do immune cells support and shape the brain in health, disease, and aging?

Authors:  Michal Schwartz; Jonathan Kipnis; Serge Rivest; Alexandre Prat
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

5.  CD4(+) T cells confer anxiolytic and antidepressant-like effects, but enhance fear memory processes in Rag2(-/-) mice.

Authors:  Sarah M Clark; Jennifer A Soroka; Chang Song; Xin Li; Leonardo H Tonelli
Journal:  Stress       Date:  2016-05       Impact factor: 3.493

Review 6.  Human immune system during sleep.

Authors:  Nayyab Asif; Razia Iqbal; Chaudhry Fahad Nazir
Journal:  Am J Clin Exp Immunol       Date:  2017-12-20

Review 7.  Sleep and immune function.

Authors:  Luciana Besedovsky; Tanja Lange; Jan Born
Journal:  Pflugers Arch       Date:  2011-11-10       Impact factor: 3.657

8.  Microglial activation - tuning and pruning adult neurogenesis.

Authors:  Christine T Ekdahl
Journal:  Front Pharmacol       Date:  2012-03-09       Impact factor: 5.810

9.  Taking the Perspective that a Depressive State Reflects Inflammation: Implications for the Use of Antidepressants.

Authors:  Jill Leslie Littrell
Journal:  Front Psychol       Date:  2012-08-17

10.  Treating depression and depression-like behavior with physical activity: an immune perspective.

Authors:  Harris A Eyre; Evan Papps; Bernhard T Baune
Journal:  Front Psychiatry       Date:  2013-02-04       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.